We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.02B
AUM Growth
-$31.8M
Cap. Flow
+$159M
Cap. Flow %
3.95%
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208

Top Buys

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$191M
2
SMAR
Smartsheet Inc.
SMAR
+$188M
3
FYBR
Frontier Communications
FYBR
+$124M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$95M
5
ALTR
Altair Engineering Inc
ALTR
+$92.6M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$234M
2
MRO
Marathon Oil Corporation
MRO
+$222M
3
SRCL
Stericycle Inc
SRCL
+$172M
4
AXNX
Axonics, Inc. Common Stock
AXNX
+$150M
5
PRFT
Perficient Inc
PRFT
+$79.6M

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Energy 15.79%
3 Communication Services 7.77%
4 Consumer Staples 7.72%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
201
AbbVie
ABBV
$432B
$1.33M 0.03%
7,488
+6,342
+553% +$1.17M
ADPT icon
202
Adaptive Biotechnologies
ADPT
$3.89B
$1.28M 0.03%
213,829
+48,555
+29% +$268K
KALA icon
203
KALA BIO
KALA
$14M
$1.24M 0.03%
3,579
+326
+10% +$103K
AFYA icon
204
Afya
AFYA
$1.25B
$1.24M 0.03%
77,815
+16,918
+28% +$279K
SNDX icon
205
Syndax Pharmaceuticals
SNDX
$1.79B
$1.19M 0.03%
90,232
+751
+0.8% +$12.9K
ALC icon
206
Alcon
ALC
$34.8B
$1.19M 0.03%
14,039
+2,030
+17% +$183K
ATXS
207
DELISTED
Astria Therapeutics
ATXS
$1.16M 0.03%
129,666
+5,464
+4% +$58K
RCUS icon
208
Arcus Biosciences
RCUS
$3.62B
$1.14M 0.03%
76,646
+44,784
+141% +$731K
ALLK
209
DELISTED
Allakos
ALLK
$1.13M 0.03%
936,797
+159,095
+20% +$167K
BCYC
210
Bicycle Therapeutics
BCYC
$287M
$1.12M 0.03%
80,236
+44,260
+123% +$949K
MLTX icon
211
MoonLake Immunotherapeutics
MLTX
$1.54B
$1.12M 0.03%
20,740
+4,740
+30% +$242K
AURA icon
212
Aura Biosciences
AURA
$810M
$1.12M 0.03%
136,516
+29,618
+28% +$279K
IOVA icon
213
Iovance Biotherapeutics
IOVA
$2.72B
$1.11M 0.03%
149,913
+36,136
+32% +$335K
ALCY
214
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
$1.1M 0.03%
100,248
– –
ARQT icon
215
Arcutis Biotherapeutics
ARQT
$3.27B
$1.08M 0.03%
77,555
-14,464
-16% -$158K
HYAC
216
DELISTED
Haymaker Acquisition Corp 4
HYAC
$1.08M 0.03%
100,248
– –
MIRM icon
217
Mirum Pharmaceuticals
MIRM
$5.91B
$1.04M 0.03%
25,059
+8,521
+52% +$355K
BOX icon
218
Box
BOX
$4.56B
$1.03M 0.03%
+32,500
New +$1.07M
KPTI icon
219
Karyopharm Therapeutics
KPTI
$44.4M
$1M 0.02%
98,915
+19,170
+24% +$232K
SKIL icon
220
Skillsoft
SKIL
$76M
$999K 0.02%
41,692
– –
LION icon
221
Lionsgate Studios
LION
$3.93B
$994K 0.02%
130,774
– –
BAX icon
222
Baxter International
BAX
$14.1B
$980K 0.02%
33,604
-8,939
-21% -$301K
SONO icon
223
Sonos
SONO
$1.86B
$978K 0.02%
+65,000
New +$875K
ITOS
224
DELISTED
iTeos Therapeutics
ITOS
$965K 0.02%
125,589
+59,649
+90% +$513K
BLCO icon
225
Bausch + Lomb
BLCO
$5.93B
$947K 0.02%
52,460
+13,460
+35% +$263K
7 8
9
10 11

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2024 Portfolio in Review

As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $159M of net new capital in Q4 2024, opening 130 new positions and adding to 130 existing holdings. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

On the sell side, the largest reduction was US Steel, an estimated $62.2M trimmed.

  • UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
  • UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
  • UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
  • UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
  • UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
  • UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.